| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 09/06/2000 | EP1032304A1 Reagent for tumor therapy and/or imaging |
| 09/05/2000 | US6114321 Porphyrin derivatives, pharmaceutical agents that contain the latter, and their use in photodynamic therapy and MRI diagnosis |
| 09/05/2000 | US6114320 Therapeutic treatment for VEGF related ocular diseases |
| 08/31/2000 | WO2000049937A2 Trpm-2 antisense therapy |
| 08/31/2000 | WO2000029003A3 Method for preventing and reversing atherosclerosis in mammals |
| 08/31/2000 | CA2850318A1 Trpm-2 antisense therapy |
| 08/31/2000 | CA2371814A1 Trpm-2 antisense therapy |
| 08/30/2000 | EP1030686A2 Lyophilizate of lipid complex of water insoluble porphyrins |
| 08/30/2000 | EP0668772B1 Specific immune system modulation |
| 08/30/2000 | CN1265039A Use of texaphyrin in prepn. of medicament for use in ocular diagnosis and therapy |
| 08/29/2000 | US6110161 Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle |
| 08/24/2000 | WO1999066831A3 Utilization of 5-aminolevulinic acid or a derivative thereof for photodynamic diagnosis or photodynamic therapy of diseases of the parodontium and teeth |
| 08/23/2000 | EP1028756A1 Water soluble paclitaxel derivatives |
| 08/22/2000 | US6107466 Acceleration of wound healing by photodynamic therapy |
| 08/22/2000 | US6107326 Concurrent with polylysine; sterilization |
| 08/16/2000 | EP1027098A1 Electrically activated substance and method for making the same |
| 08/16/2000 | EP1027093A1 Method and apparatus for applying 5-aminolevulinic acid |
| 08/16/2000 | EP1027034A1 Marker for intestinal diagnosis and intestinal therapy |
| 08/16/2000 | EP1027016A1 Methods and pharmaceutical compositions for the closure of retinal breaks |
| 08/15/2000 | US6103706 Administering a phthalocyanine formulated in a liposome comprising 1-palmitoyl-2-oleoyl-sn-glycero-phosphocholine and 1,2-dioleoyl-sn-glycero-3-(phospho-l-serine) and exposing to light |
| 08/15/2000 | US6103271 Adding primary solution to first chamber, secondary solution to second chamber, forming interface at porous barrier, moving interface, forming microcapsules, isolating by filtration |
| 08/10/2000 | WO2000045858A1 Collagen-based delivery of radioactivity for use in brachytherapy |
| 08/10/2000 | WO2000045857A2 Metal macrocycles for two-step forms of radiotherapy |
| 08/10/2000 | WO2000045845A2 Liposome composition and method for administration of a radiosensitizer |
| 08/10/2000 | WO2000045826A1 Process for making ceramic microspheres |
| 08/10/2000 | WO2000045823A1 Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo |
| 08/10/2000 | CA2361601A1 Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo |
| 08/10/2000 | CA2360941A1 Liposome composition and method for administration of a radiosensitizer |
| 08/09/2000 | EP1024832A1 METHODS FOR PROMOTING CELL TRANSFECTION $i(IN VIVO) |
| 08/09/2000 | EP0825851A4 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
| 08/08/2000 | US6100392 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 08/08/2000 | US6100290 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 08/08/2000 | US6100243 Method of sensitizing tumor cells with adenovirus E1A |
| 08/08/2000 | US6099864 In situ activation of microcapsules |
| 08/08/2000 | CA1341077C Luminide and macroluminide class of pharmaceuticals |
| 08/03/2000 | WO2000044682A1 Biodegradable glass compositions and methods for radiation therapy |
| 08/02/2000 | EP1023399A1 Novel methods of syntheses of phthalocyanine compounds |
| 08/02/2000 | EP0828825A4 Methods of use of phthalocyanines to inactivate blood borne parasites |
| 08/01/2000 | US6096734 Photosensitizers for sensitizing cells |
| 08/01/2000 | US6096290 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 08/01/2000 | US6095147 Method for photo-altering a biological system to improve biological effect |
| 07/27/2000 | WO2000043045A1 Method for improved radiation therapy |
| 07/27/2000 | CA2358989A1 Method for improved radiation therapy |
| 07/26/2000 | EP1021712A4 Phosphorescent dendritic macromolecular compounds for imaging tissue oxygen |
| 07/26/2000 | EP1021712A1 Phosphorescent dendritic macromolecular compounds for imaging tissue oxygen |
| 07/20/2000 | WO2000041727A1 Transcutaneous photodynamic treatment of targeted cells |
| 07/20/2000 | WO2000041726A2 Noninvasive vascular therapy |
| 07/20/2000 | WO2000041725A2 Therapeutic compositions for metabolic bone disorders or bone metastases |
| 07/20/2000 | CA2358662A1 Therapeutic compositions for metabolic bone disorders or bone metastases |
| 07/20/2000 | CA2356776A1 Transcutaneous photodynamic treatment of targeted cells |
| 07/20/2000 | CA2356532A1 Noninvasive vascular therapy |
| 07/19/2000 | EP1020180A2 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 07/19/2000 | EP1019037A1 Medicament containing delta-aminolevulinic acid |
| 07/19/2000 | EP0722320B1 Use of nitric oxide-releasing compounds as medicaments for hypoxic cell radiation sensitization |
| 07/19/2000 | CN1260724A Nanoscale particles having iron oxide-containing core enveloped by at least two shells |
| 07/18/2000 | US6090800 Reaction product containing dexamethasone |
| 07/18/2000 | US6090788 Irradiating the area of skin or nail with a light beam having at least one wavelength absorbable by the pathogen to destruct the fungal pathogen |
| 07/18/2000 | US6090599 Contacting erythrocyte composition with pc4 dye and light from source emitting greater than 80 percent red light at wavelength of 690 to 700 nanometers |
| 07/13/2000 | WO2000040266A2 Targeting of sebaceous follicles as a treatment of sebaceous gland disorders |
| 07/13/2000 | WO2000040229A2 Synergistic tumorcidal response induced by histamine |
| 07/13/2000 | CA2360202A1 Energy activatable material for the treatment of sebaceous gland disorders |
| 07/13/2000 | CA2358754A1 Synergistic tumorcidal response induced by histamine |
| 07/12/2000 | EP1017397A1 Photosensitizer conjugates for pathogen targeting |
| 07/12/2000 | EP0642342B1 Selective cell inactivation in blood |
| 07/12/2000 | CN1260006A Complex formation between dsDNA and oligomer of heterocycles |
| 07/11/2000 | US6088613 Method of magnetic resonance focused surgical and therapeutic ultrasound |
| 07/11/2000 | US6087141 Inactivation of intracellular or extracellular virus within a biocompatible sample; insertion of sample into radiation sensitizer and exposure to ultraviolet radiation or incubate sample with solvent, a detergent or heat treat |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038716A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038682A1 Anti-hiv infection agents and method for treating hiv infection |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO1999055383A3 Improvements in or relating to diagnostic/therapeutic agents |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356547A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356453A1 Anti-hiv infection agents and method for treating hiv infection |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/05/2000 | EP1015039A1 Oxygen delivery agents and uses for the same |
| 07/05/2000 | EP1015033A2 Substituted perylenequinones for use in photodynamic therapy |
| 07/05/2000 | EP1015030A2 Photochemotherapeutic compositions |
| 07/04/2000 | US6083149 Magnetic field device and method for inhibiting angiogenesis and retarding growth rates of tumors in mammals |
| 06/29/2000 | WO2000037927A1 High energy phototherapeutic agents |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 06/29/2000 | WO2000036983A1 Pegylated photosensitizers for abnormal tissue treatment |
| 06/29/2000 | CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia |
| 06/28/2000 | EP1011696A1 Treatment of stress and preconditioning against stress |
| 06/27/2000 | US6080777 Taxol as a radiation sensitizer |
| 06/27/2000 | US6080411 Inhibitory effects of synthetic and natural colorants on carcinogenesis III |
| 06/22/2000 | WO2000001350A3 Material for modifying the optical properties of different cells, device for applying such a material, diagnostic apparatus for determining the optical properties of cells and device for irradiating cells |
| 06/21/2000 | EP1010426A1 Immunosuppression by photochemotherapy |
| 06/21/2000 | EP1009433A1 Therapeutic composition and method of treatment |